|Articles|May 1, 2020
- Pharmaceutical Executive-05-01-2020
- Volume 40
- Issue 5
Pharmaceutical Executive, May 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec's Emerging Pharma Leaders 2020about 6 years ago
AI: Kickstarting the Race Against COVID-19about 6 years ago
Competition for Biotech CFOs is Heating Upabout 6 years ago
Biopharma Sustainability Considered Essentialabout 6 years ago
CFOs Outlook: Forging a Sustainable Futureabout 6 years ago
Drive for COVID-19 Therapies Raises Patent and Pricing Issuesabout 6 years ago
Biotech in the Age of COVID: The Pain and the Gainabout 6 years ago
A New, Less Friendly Normal Looms for European Drugmakersabout 6 years ago
How Prepared Were Doctors for the COVID Digital Upswing?about 6 years ago
Pharmaceutical Executive, May 2020 Issue (PDF)Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Nuvation Bio’s Approach to Building a Compelling Narrative
2
Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform
3
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
4
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
5